Ge Li, Phd

Biography

Dr. Ge Li is the Founder, Chairman and Chief Executive Officer of WuXi PharmaTech (NYSE: WX), a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology and medical device industries. Dr. Li studied at Peking University as an undergraduate and received his Ph.D. in Organic Chemistry from Columbia University. He began his industry career in 1993 as one of the founding scientists at Pharmacopeia, Inc. (NASDAQ: PCOP). In 2000, Dr. Li moved back to Shanghai to found WuXi PharmaTech and has since been its Chairman and CEO. Under Dr. Li’s leadership, WuXi has grown from 4 founders and a single laboratory of 7,000 square feet in Year 2000 to a global operation with over 9,000 employees and facilities totaling 5 million square feet for world-class research, development and manufacturing to help advance some of the most innovative healthcare products for patients around the world. Dr. Li also serves as a board member of Hua Medicine, Adagene, Phagelux, Shanghai Hile Biopharmaceutical Co. Ltd., and serves as an advisory board member of the Shanghai Institute for Advanced Immunochemical Studies (SIAIS) of ShanghaiTech University. Dr. Li’s entrepreneurship and achievements have won him numerous prestigious awards and honors, including “The 25 Most Influential People in Biopharma in 2015”, “Forbes 25 Notable Chinese-Americans”, “The 60 Most Influential People during 60 Years Pharmaceutical Development in China”, “Ernst & Young Entrepreneur of the Year China Award”, “The Boston Biotech Chief Executive Officers Conference Life Achievement Award”, and “The Most Innovative Leader of the Chinese Enterprises”.

Research Interest

 organic chemistry